FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024

Apr 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-04-04

Reporting Person: Raykov Rosty (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-04-04	Common shares	S	14583	$10.8943	Disposed	261471	Direct
2024-04-04	Common shares	S	29700	$10.8932	Disposed	231771	Direct
2024-04-05	Common shares	S	44300	$10.7510	Disposed	187471	Direct

Footnotes

F1: Represents shares sold pusuant to a 10b5-1 plan dated December 14, 2023.

F2: Represents shares sold pusuant to a 10b5-1 plan dated December 14, 2023.

F3: Represents shares sold pusuant to a 10b5-1 plan dated December 14, 2023.